Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2Upper Tract Urothelial Carcinoma 1Unresectable Hepatocellular Carcinoma 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1Radiation Injuries 1Pathologic Complete Response 1Pancreatic Cancer Liver Metastases 1Neoadjuvant Immunotherapy 1Muscle-invasive Bladder Cancer 1Locally Advanced Rectal Adenocarcinoma 1Locally Advanced Pancreatic Cancer 1Locally Advanced Cervical Carcinoma 1Hyperthermia 1HER2-Negative Locally Advanced Breast Cancer 1Gynecologic Cancers 1Gastrointestinal Neoplasms 1Gastric Cancer With Liver Metastases 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Advanced Rectal Cancer 1

Interventions

Radiotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × HER2-Negative Locally Advanced Breast Cancer × Immunotherapy × Clear all
NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
170 enrolled
Breast

HER2-Negative Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡